Long-term Cost-effectiveness of Statin Treatment for Primary Prevention of Cardiovascular Disease in the Elderly.

about

Dyslipidaemia in the elderly: to treat or not to treat?Rosuvastatin limits the activation of hepatic stellate cells in diet-induced obese mice.

P2860

Q50180407-36251F10-E5B6-4A54-AF0C-06ABB22FCC00 Q51479885-1F27165E-A860-4DAD-9EC0-BEAF27E0777A

P2860

Long-term Cost-effectiveness of Statin Treatment for Primary Prevention of Cardiovascular Disease in the Elderly.

Item

http://www.wikidata.org/entity/Q51035329

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Long-term Cost-effectiveness o ...... scular Disease in the Elderly.

@en

Long-term Cost-effectiveness o ...... scular Disease in the Elderly.

@nl

type

Item

label

Long-term Cost-effectiveness o ...... scular Disease in the Elderly.

@en

Long-term Cost-effectiveness o ...... scular Disease in the Elderly.

@nl

prefLabel

Long-term Cost-effectiveness o ...... scular Disease in the Elderly.

@en

Long-term Cost-effectiveness o ...... scular Disease in the Elderly.

@nl

P1476

Long-term Cost-effectiveness o ...... scular Disease in the Elderly.

@en

P2093

Ai Leng Khoo

http://www.w3.org/2001/XMLSchema#string

Boon Peng Lim

http://www.w3.org/2001/XMLSchema#string

Liang Lin

http://www.w3.org/2001/XMLSchema#string

Monica Teng

http://www.w3.org/2001/XMLSchema#string

Quek Wei Yong

http://www.w3.org/2001/XMLSchema#string

Raymond Chee Seong Seet

http://www.w3.org/2001/XMLSchema#string

Tiong Cheng Yeo

http://www.w3.org/2001/XMLSchema#string

Ying Jiao Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

Statins for the primary prevention of cardiovascular disease

The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials

Aspirin, statins, or both drugs for the primary prevention of coronary heart disease events in men: a cost-utility analysis

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial.

Meta-analysis of statin effects in women versus men.

Sex differences in quality of life after ischemic stroke.

Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization.

P304

187-197

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10557-015-6584-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25860556

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease

Long-term Cost-effectiveness of Statin Treatment for Primary Prevention of Cardiovascular Disease in the Elderly.

about

P2860

P2860

Long-term Cost-effectiveness of Statin Treatment for Primary Prevention of Cardiovascular Disease in the Elderly.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921